Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2021 Apr 30

PMID 33919884

Citations 5

Authors

Eric W Li

Yongsheng Bai

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) perform their functions through targeting messenger RNAs (mRNAs). X chromosome-located (X-linked) miRNAs have a broad role in cell lineage determination, immune regulation, and oncogenesis. The regulating roles of miRNAs in cancer and immunity are often altered when aberrant expression happens. Sex-biased genes could contribute to cancer sex bias in the context of their expression change due to targeting miRNAs. How biological roles and associations with immune cell abundance levels for sex-biased gene-miRNA pairs in gender-related cancer (e.g., breast cancer) change due to the alteration of their expression pattern to identify candidate therapeutic markers has not been investigated thoroughly. Upon analyzing anti-correlated genes and miRNAs within significant clusters of 12 The Cancer Genome Atlas (TCGA) cancer types and the list of sex-biased genes and miRNAs reported from previous studies, 125 sex-biased genes (11 male-biased and 114 female-biased) were identified in breast cancer (BC). Seventy-three sex-biased miRNAs (40 male-biased and 33 female-biased) were identified across 5 out of 12 cancers (head and neck squamous cell carcinoma (HNSC), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), and lung adenocarcinoma (LUAD)). Correlation between the BC sex-biased genes and tumor infiltrating immune cell types was further evaluated. We found eight genes having high correlation with immune infiltration. Fifteen candidate female-biased BC genes targeted by 3 X-linked miRNAs (, and ) were pinpointed in this study. Our computational result indicates that many identified female-biased genes which have positive associations with immune cell abundance levels could serve as alternative therapeutic markers. Our analysis suggests that female-biased expression of BC candidate genes is likely influenced by their targeting miRNA(s).

Citing Articles

Sex differences in disease: sex chromosome and immunity.

Feng Z, Liao M, Zhang L J Transl Med. 2024; 22(1):1150.

PMID: 39731171 PMC: 11673612. DOI: 10.1186/s12967-024-05990-2.

Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility.

Caserta S, Gangemi S, Murdaca G, Allegra A Int J Mol Sci. 2023; 24(14).

PMID: 37511303 PMC: 10380791. DOI: 10.3390/ijms241411544.

Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods.

Harangus A, Lajos R, Budisan L, Zanoaga O, Ciocan C, Bica C J Pers Med. 2022; 12(12).

PMID: 36556276 PMC: 9780989. DOI: 10.3390/jpm12122056.

Bioinformatics Analysis Reveals the Related Role of miR-511-5p in the Progression of Breast Cancer.

Wang T, Liu J, Zhong R, Zhang Y, Sun Z, Li J J Healthc Eng. 2022; 2022:7146338.

PMID: 35186236 PMC: 8853816. DOI: 10.1155/2022/7146338.

ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.

Lin Y, Li C, Xiong W, Fan L, Pan H, Li Y Cell Death Dis. 2021; 12(11):1042.

PMID: 34725332 PMC: 8560752. DOI: 10.1038/s41419-021-04338-8.

References

Dai R, Ahmed S . Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases. Ther Clin Risk Manag. 2014; 10:151-63. PMC: 3949753. DOI: 10.2147/TCRM.S33517. View

Dai X, Ding L, Liu H, Xu Z, Jiang H, Handelman S . Identifying Interaction Clusters for MiRNA and MRNA Pairs in TCGA Network. Genes (Basel). 2019; 10(9). PMC: 6770970. DOI: 10.3390/genes10090702. View

Huang D, Sherman B, Tan Q, Kir J, Liu D, Bryant D . DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007; 35(Web Server issue):W169-75. PMC: 1933169. DOI: 10.1093/nar/gkm415. View

Pena-Chilet M, Martinez M, Perez-Fidalgo J, Peiro-Chova L, Oltra S, Tormo E . MicroRNA profile in very young women with breast cancer. BMC Cancer. 2014; 14:529. PMC: 4223555. DOI: 10.1186/1471-2407-14-529. View

Liu K, Wang L, Sun E . Prognostic value of miR-221 in human malignancy: evidence from 3041 subjects. BMC Cancer. 2019; 19(1):867. PMC: 6717359. DOI: 10.1186/s12885-019-6079-1. View

Schiffer V, Janssen E, van Bussel B, Jorissen L, Tas J, Sels J . The "sex gap" in COVID-19 trials: a scoping review. EClinicalMedicine. 2020; 29:100652. PMC: 7701906. DOI: 10.1016/j.eclinm.2020.100652. View

Senger J, Adams S, Kanthan R . Invasive lobular carcinoma of the male breast - a systematic review with an illustrative case study. Breast Cancer (Dove Med Press). 2017; 9:337-345. PMC: 5439541. DOI: 10.2147/BCTT.S126341. View

Upadhyay R, Kumar P, Sharma D, Haresh K, Gupta S, Julka P . Invasive lobular carcinoma of the male breast: A rare histology of an uncommon disease. J Egypt Natl Canc Inst. 2015; 28(1):55-8. DOI: 10.1016/j.jnci.2015.10.001. View

Quinlan A, Hall I . BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010; 26(6):841-2. PMC: 2832824. DOI: 10.1093/bioinformatics/btq033. View

10.

le Sage C, Nagel R, Egan D, Schrier M, Mesman E, Mangiola A . Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007; 26(15):3699-708. PMC: 1949005. DOI: 10.1038/sj.emboj.7601790. View

11.

Pinheiro I, Dejager L, Libert C . X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays. 2011; 33(11):791-802. DOI: 10.1002/bies.201100047. View

12.

Chen P, He Y, Huang X, Tao S, Wang X, Yan H . modulates s-mediated autophagy in human luminal breast cancer cell lines. Oncotarget. 2017; 8(46):80709-80721. PMC: 5655233. DOI: 10.18632/oncotarget.21080. View

13.

Gausman J, Langer A . Sex and Gender Disparities in the COVID-19 Pandemic. J Womens Health (Larchmt). 2020; 29(4):465-466. DOI: 10.1089/jwh.2020.8472. View

14.

Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao H . Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients. Cancer Cell. 2016; 29(5):711-722. PMC: 4864951. DOI: 10.1016/j.ccell.2016.04.001. View

15.

Cho W . OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007; 6:60. PMC: 2098778. DOI: 10.1186/1476-4598-6-60. View

16.

Zellinger B, Bodenhofer U, Englander I, Kronberger C, Strasser P, Grambozov B . Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer. Genes (Basel). 2020; 11(12). PMC: 7759924. DOI: 10.3390/genes11121404. View

17.

Han S, Kim H, Gwak J, Kim M, Chung Y, Park S . MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer. J Breast Cancer. 2017; 20(1):35-44. PMC: 5378578. DOI: 10.4048/jbc.2017.20.1.35. View

18.

Guo S, Zhou Y, Zeng P, Xu G, Wang G, Cui Q . Identification and analysis of the human sex-biased genes. Brief Bioinform. 2016; 19(2):188-198. DOI: 10.1093/bib/bbw125. View

19.

Cascio S, DAndrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V . miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol. 2010; 224(1):242-9. DOI: 10.1002/jcp.22126. View

20.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View